Display options
Cite
Cooke ME, Gilman JM, Lamberth E, et al. Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. Front Psychiatry. 2021;12:689957doi: 10.3389/fpsyt.2021.689957.
Cooke, M. E., Gilman, J. M., Lamberth, E., Rychik, N., Tervo-Clemmens, B., Evins, A. E., & Schuster, R. M. (2021). Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. Frontiers in psychiatry, 12689957. https://doi.org/10.3389/fpsyt.2021.689957
Cooke, Megan E, et al. "Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents." Frontiers in psychiatry vol. 12 (2021): 689957. doi: https://doi.org/10.3389/fpsyt.2021.689957
Cooke ME, Gilman JM, Lamberth E, Rychik N, Tervo-Clemmens B, Evins AE, Schuster RM. Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. Front Psychiatry. 2021 Jul 01;12:689957. doi: 10.3389/fpsyt.2021.689957. eCollection 2021. PMID: 34276449; PMCID: PMC8280499.
Copy Download .nbib Format: NLM
Share it on

Front Psychiatry. 2021 Jul 01;12:689957. doi: 10.3389/fpsyt.2021.689957. eCollection 2021.

Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents.

Frontiers in psychiatry

Megan E Cooke, Jodi M Gilman, Erin Lamberth, Natali Rychik, Brenden Tervo-Clemmens, A Eden Evins, Randi M Schuster

Affiliations

  1. Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  2. Harvard Medical School, Boston, MA, United States.

PMID: 34276449 PMCID: PMC8280499 DOI: 10.3389/fpsyt.2021.689957

[No abstract available.]

Copyright © 2021 Cooke, Gilman, Lamberth, Rychik, Tervo-Clemmens, Evins and Schuster.

Keywords: adolescents; anxiety; cannabis; cannabis abstinence; contingency management; depression; youth

Conflict of interest statement

AE has received research grant support to her institution from Pfizer Inc, Forum Pharmaceuticals, and GSK, consultation fees from Charles River Analytics, and honoraria for advisory work from Pfizer,

References

  1. Neuropsychopharmacology. 2017 Oct;42(11):2259-2271 - PubMed
  2. J Appl Behav Anal. 1986 Summer;19(2):197-202 - PubMed
  3. J Abnorm Psychol. 1995 Feb;104(1):3-14 - PubMed
  4. Psychopharmacology (Berl). 2002 Feb;159(4):379-87 - PubMed
  5. J Abnorm Psychol. 1991 Aug;100(3):316-36 - PubMed
  6. J Stud Alcohol Drugs. 2011 Jan;72(1):106-16 - PubMed
  7. Am J Psychiatry. 2012 Feb;169(2):152-9 - PubMed
  8. J Stud Alcohol Drugs. 2013 Jul;74(4):642-51 - PubMed
  9. Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43 - PubMed
  10. Drug Alcohol Depend. 1986 Jul;17(4):311-22 - PubMed
  11. Am J Psychiatry. 2001 Dec;158(12):2033-7 - PubMed
  12. J Addict Med. 2014 Mar-Apr;8(2):130-6 - PubMed
  13. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20;107:110205 - PubMed
  14. PLoS One. 2013 Oct 24;8(10):e76635 - PubMed
  15. Br J Psychiatry. 2002 Mar;180:216-21 - PubMed
  16. Drug Alcohol Depend. 2002 Jan 1;65(2):179-89 - PubMed
  17. Cannabis Cannabinoid Res. 2016 Jun 01;1(1):131-138 - PubMed
  18. J Subst Abuse Treat. 2009 Jun;36(4):400-13 - PubMed
  19. Neuroimage. 2010 Jan 1;49(1):1133-43 - PubMed
  20. Psychol Addict Behav. 2015 Sep;29(3):627-32 - PubMed
  21. Psychol Addict Behav. 2014 Mar;28(1):154-62 - PubMed
  22. Curr Opin Psychiatry. 2006 May;19(3):233-8 - PubMed
  23. Drug Alcohol Depend. 2005 May 9;78(2):205-10 - PubMed
  24. BMJ. 2014 Feb 13;348:g1151 - PubMed
  25. Drug Alcohol Depend. 2011 Dec 1;119(1-2):123-9 - PubMed
  26. Drug Alcohol Depend. 2016 Oct 01;167:199-206 - PubMed
  27. J Consult Clin Psychol. 2000 Dec;68(6):1051-61 - PubMed
  28. J Psychopharmacol. 2020 Feb;34(2):197-210 - PubMed
  29. Biol Psychiatry. 2014 Aug 1;76(3):176-85 - PubMed
  30. J Child Psychol Psychiatry. 2006 Oct;47(10):1031-40 - PubMed
  31. Schizophr Res. 2018 Apr;194:47-54 - PubMed
  32. Exp Clin Psychopharmacol. 2000 Nov;8(4):509-17 - PubMed
  33. Am J Psychiatry. 2009 Jun;166(6):702-10 - PubMed
  34. Am J Psychiatry. 2004 Nov;161(11):1967-77 - PubMed
  35. Drug Alcohol Depend. 2013 Apr 1;129(1-2):49-53 - PubMed
  36. Am J Psychiatry. 1995 Jan;152(1):45-52 - PubMed
  37. Psychopharmacology (Berl). 1989;97(1):23-9 - PubMed
  38. J Prim Prev. 2016 Jun;37(3):303-9 - PubMed
  39. Subst Abuse Rehabil. 2017 Apr 27;8:9-37 - PubMed
  40. J Consult Clin Psychol. 2000 Apr;68(2):250-7 - PubMed
  41. PLoS One. 2015 Mar 23;10(3):e0119150 - PubMed
  42. Int J Drug Policy. 2014 Mar;25(2):308-19 - PubMed
  43. Psychopharmacology (Berl). 2017 Dec;234(23-24):3431-3442 - PubMed
  44. Addiction. 2005 Apr;100(4):525-35 - PubMed
  45. J Clin Psychiatry. 2018 Oct 30;79(6): - PubMed
  46. J Stud Alcohol Drugs. 2013 Sep;74(5):720-6 - PubMed
  47. Biol Psychiatry. 2016 Apr 1;79(7):613-9 - PubMed
  48. Addiction. 2011 Mar;106(3):499-506 - PubMed
  49. J Abnorm Psychol. 2003 Aug;112(3):393-402 - PubMed
  50. Life Sci. 1994;55(3):179-87 - PubMed
  51. J Environ Public Health. 2015;2015:476017 - PubMed
  52. Drug Alcohol Depend. 2000 Feb 1;58(1-2):103-9 - PubMed
  53. Depress Anxiety. 2016 Apr;33(4):332-8 - PubMed
  54. Addict Behav. 2007 Jul;32(7):1384-94 - PubMed

Publication Types